Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Ear Hear. 2019 Nov-Dec;40(6):1261–1266. doi: 10.1097/AUD.0000000000000731

Figure 1.

Figure 1.

Results from the initial test of CEDRA (n=307), showing A: The probability of a diagnosis of targeted ear disease(s) by a certified neurotologist plotted against the CEDRA score. B: The relationship of the CEDRA scores to the missed diseases (squares) and unnecessary referrals (crosses). BOTH: The vertical dashed line shows the recommended consumer cut-off score of 4 or higher.